tiprankstipranks
Neuroscientific Biopharmaceuticals Ltd. (AU:NSB)
ASX:NSB
Australian Market

Neuroscientific Biopharmaceuticals Ltd. (NSB) Cash flow

1 Followers

Neuroscientific Biopharmaceuticals Ltd. Cash Flow

AU:NSB's free cash flow for Q4 2022 was AU$―. For the 2022 fiscal year, AU:NSB's free cash flow was decreased by AU$-4.31M and operating cash flow was AU$―. See a summary of the company’s cash flow.
Cash Flow
TTM
Jun 22Jun 21Jun 20Jun 19
Operating Cash Flow
-----
Investing Cash Flow
-AU$ -3.87KAU$ -29.88KAU$ -2.38KAU$ -19.08K
Financing Cash Flow
--AU$ 13.51MAU$ 960.80KAU$ 5.93M
Cash Flow From Discontinued Operation
-----
Other Cash Adjustment Inside Changein Cash
-----
End Cash Position
-AU$ 7.22MAU$ 14.16MAU$ 3.29MAU$ 4.61M
Income Tax Paid Supplemental Data
-----
Interest Paid Supplemental Data
--AU$ 63.00AU$ 3.42KAU$ 465.00
Issuance Of Capital Stock
--AU$ 13.51MAU$ 960.80KAU$ 5.93M
Issuance Of Debt
-----
Repayment Of Debt
-----
Free Cash Flow
-AU$ -6.95MAU$ -2.63MAU$ -2.28MAU$ -1.43M
Domestic Sales
-----
Foreign Sales
-----
Currency in AUD

Neuroscientific Biopharmaceuticals Ltd. Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis